Security key
52886X107
Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)
CUSIP: 52886X107
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 79,828,208
- Total 13F value
- $458,111,449
- Share change
- +3,328,045
- Put/Call ratio
- 15%
- SEC-reported price per share
- $5.74
- Number of holders
- 138
- Value change
- +$6,784,198
- Number of buys
- 74
- Number of sells
- 64
- Shares outstanding
- 74,507,639
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
138
Top holders
10
LXEO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Lexeo Therapeutics, Inc. SEC filings
Lexeo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52886X107
Recent filing periods:
Ownership snapshot
Top reported holders of LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: Janus Henderson Group Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Janus Henderson Group Ltd. leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership
Top 5
Janus Henderson Group Ltd.
10%
BALYASNY ASSET MANAGEMENT L.P.
9.7%
Paradigm Biocapital Advisors LP
8.3%
Vestal Point Capital, LP
7.5%
CITADEL ADVISORS LLC
7.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Janus Henderson Group Ltd. |
13D/G
13F
JANUS HENDERSON GROUP PLC · Company
|
10%
|
$65,914,563
7,291,434 shares
|
+$10,720,599 | 28 Nov 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
13F
Company
|
9.7%
|
$41,191,067
7,176,144 shares
|
-$260,659 | 31 Mar 2026 |
| Paradigm Biocapital Advisors LP |
13F
13D/G
Company
|
8.3%
from 13D/G
|
$47,298,556
4,763,198 shares
|
— | 31 Dec 2025 |
| Vestal Point Capital, LP |
13F
13D/G
Company
|
7.5%
from 13D/G
|
$44,436,750
4,475,000 shares
|
— | 31 Dec 2025 |
| CITADEL ADVISORS LLC |
13D/G
13F
Kenneth Griffin · Company
|
7.4%
|
$40,851,767
5,498,219 shares
|
+$1,219,315 | 31 Dec 2025 |
| Affinity Asset Advisors, LLC |
13D/G
13F
Company
|
7.1%
|
$51,813,451
5,217,660 shares
|
+$9,589,340 | 22 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
138
Shares
79,828,208
Rows available
138
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
138
Q1 2026 holders
138
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend